Concepedia

Publication | Open Access

Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris

516

Citations

18

References

2002

Year

Abstract

Results show evidence of favorable anti-ischemic effects with Ad5-FGF4 compared with placebo, and it appears to be safe. Angiogenic gene transfer with Ad5-FGF4 shows promise as a new therapeutic approach to the treatment of angina pectoris.

References

YearCitations

Page 1